SCHEMBL1006121

SCHEMBL1006121

CCC12CCC(C1)C1CCCC12C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6550845 0.73
SCHEMBL5644047 0.64 HSD11B1 (0.31)
SCHEMBL21807831 0.60
SCHEMBL28576615 0.59 CYP1A2 (0.32) CYP1A2
SCHEMBL7252902 0.59 HSD11B1 (0.30)
SCHEMBL19064327 0.59 CYP2C19 (0.39)
SCHEMBL5644042 0.58 CYP3A4 (0.35) CYP1A2
SCHEMBL22576437 0.58 CYP2C19 (0.38) CYP1A2
SCHEMBL13464472 0.58 CYP1A2 (0.51) CYP1A2
SCHEMBL16767017 0.58 HSD17B10 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1629075-B1 BATHROOM CLEANING COMPOSITION COLGATE PALMOLIVE CO (US) 2009-11-04 EP claimed
US-20060052276-A1 Armoise Tunisian oil, para-t-butylphenylacetonitrile, dihydrolinalol, N-ethyl-N-(3-methylphenyl)propionamide, 4-(5-ethylbicyclo[2.2.1]heptyl-2)-cyclohexanol, ethyltricyclo[5.2.1.0{2,6}]decane-2-carboxylate; inhibiting the biotransformation of androstadienols to androstenones QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-03-09 US claimed
EP-1523543-A1 IMPROVEMENTS IN OR RELATING TO PERFUME COMPOSITIONS Quest International Services B.V. (NL) 2005-04-20 EP claimed
EP-1029032-B1 LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS UNILEVER PLC (GB) 2004-03-03 EP claimed
WO-2004009750-A1 IMPROVEMENTS IN OR RELATING TO PERFUME COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2004-01-29 WO claimed
EP-2270493-B1 METHOD FOR SCREENING OLFACTORY SENSIBILITY INHIBITOR KAO CORP (JP) 2020-03-18 EP disclosed
US-10006151-B2 Polyurethane fiber TORAY OPELONTEX CO., LTD. (JP) 2018-06-26 US disclosed
EP-2947185-B1 POLYURETHANE FIBER AND ITS USE TORAY OPELONTEX CO LTD (JP) 2018-02-28 EP disclosed
US-20160002827-A1 POLYURETHANE FIBER TORAY OPELONTEX CO., LTD. (JP) 2016-01-07 US disclosed
EP-2947185-A1 POLYURETHANE FIBER Toray Opelontex Co., Ltd (JP) 2015-11-25 EP disclosed
US-9012153-B2 Method for screening olfactory sensibility inhibitor KAO CORPORATION (JP) 2015-04-21 US disclosed
EP-1698726-B1 Fiber product treating agent KAO CORP (JP) 2013-10-23 EP disclosed
EP-1921130-A1 METHOD OF SELECTING PERFUME INGREDIENT, METHOD OF PERFUME FORMULATION, AND TASTINESS IMPROVER Shiseido Company, Limited (JP) 2008-05-14 EP disclosed
EP-1780258-A1 Perfume composition Kao Corporation (JP) 2007-05-02 EP disclosed
US-20060198808-A1 Increasing the longevity of perfume contained in a fiber product treating agent by adding a long-chain alkyl- or alkenylamine, amine salt or quaternary ammonium salt in which the chain may be interrupted by a secondary amide group: N-[3-(dimethylamino)propyl]- stearamide or behenamide KAO CORPORATION (JP) 2006-09-07 US disclosed
EP-1698726-A1 Fiber product treating agent Kao Corporation (JP) 2006-09-06 EP disclosed
US-20060052276-A1 Armoise Tunisian oil, para-t-butylphenylacetonitrile, dihydrolinalol, N-ethyl-N-(3-methylphenyl)propionamide, 4-(5-ethylbicyclo[2.2.1]heptyl-2)-cyclohexanol, ethyltricyclo[5.2.1.0{2,6}]decane-2-carboxylate; inhibiting the biotransformation of androstadienols to androstenones QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-03-09 US disclosed
EP-1523543-A1 IMPROVEMENTS IN OR RELATING TO PERFUME COMPOSITIONS Quest International Services B.V. (NL) 2005-04-20 EP disclosed
WO-2004009750-A1 IMPROVEMENTS IN OR RELATING TO PERFUME COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2004-01-29 WO disclosed
JP-2000344636-A DEODORANT COMPOSITION KAO CORP 2000-12-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060198808-A1 Increasing the longevity of perfume contained in a fiber product treating agent by adding a long-chain alkyl- or alkenylamine, amine salt or quaternary ammonium salt in which the chain may be interrupted by a secondary amide group: N-[3-(dimethylamino)propyl]- stearamide or behenamide CERT1, FAAH, FAAH2 CYP1A2 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.